PhytoPain Pharma Provides USA Regulatory Update for Its Cannabis Inhalation Product PPP001
PhytoPain Pharma ("PPP"), a subsidiary of GrowPros Cannabis Ventures Inc. ("GrowPros" or the "Company" or "GCI") (CSE:GCI), a pharmaceutical company focused on developing and commercializing therapeutic cannabis- …